Quality of Life and Psychological Factors in Patients with Metastatic Prostate Cancer Receiving Androgen Receptor-Targeted Therapies: A Prospective Cross-Sectional Real-World Study.

Medicina (Kaunas) · 2026 · PMC13302846 · PMID 42356187

Europe PMC DOI

hedged sentence

0.0570

closest p · 1.1× alpha

0.0570

boldest claim

The sentences

borderline significancep = 0.057so close (0.05 < p ≤ 0.1)

Enzalutamide was associated with a lower likelihood of poor QoL compared to abiraterone (OR: 0.39, 95% CI: 0.18–0.88, p = 0.023), while overall treatment type showed borderline significance ( p = 0.057).

also in 7,017 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.